Published in Clin Toxicol (Phila) on January 01, 2005
Herbal hepatotoxicity in traditional and modern medicine: actual key issues and new encouraging steps. Front Pharmacol (2015) 1.04
A Chinese Herbal Decoction, Huoxue Qingyi Decoction, Promotes Rehabilitation of Patients with Severe Acute Pancreatitis: A Retrospective Study. Evid Based Complement Alternat Med (2016) 0.83
Herbal Hepatotoxicity: Clinical Characteristics and Listing Compilation. Int J Mol Sci (2016) 0.82
Causes, Features, and Outcomes of Drug-Induced Liver Injury in 69 Children from China. Gut Liver (2015) 0.78
Traditional Chinese Medicine Induced Liver Injury. J Clin Transl Hepatol (2014) 0.77
A rare case of acute hepatitis induced by use of Babchi seeds as an Ayurvedic remedy for vitiligo. BMJ Case Rep (2014) 0.75
Traditional Chinese Medicine (TCM) and Herbal Hepatotoxicity: RUCAM and the Role of Novel Diagnostic Biomarkers Such as MicroRNAs. Medicines (Basel) (2016) 0.75
CYP3A4 inhibition by Psoralea corylifolia and its major components in human recombinant enzyme, differentiated human hepatoma HuH-7 and HepaRG cells. Toxicol Rep (2015) 0.75
Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans. Eur J Nucl Med Mol Imaging (2008) 2.55
A prospective nationwide study of drug-induced liver injury in Korea. Am J Gastroenterol (2012) 2.43
Performance measurement of the microPET focus 120 scanner. J Nucl Med (2007) 2.10
Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer (2010) 1.92
Transarterial chemo-lipiodolization can reactivate hepatitis B virus replication in patients with hepatocellular carcinoma. J Hepatol (2004) 1.82
Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J Nucl Med (2006) 1.72
Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma. Antivir Ther (2011) 1.65
Reversing the silencing of reporter sodium/iodide symporter transgene for stem cell tracking. J Nucl Med (2005) 1.59
PET evidence of neuroplasticity in adult auditory cortex of postlingual deafness. J Nucl Med (2003) 1.52
A nucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. J Nucl Med (2009) 1.51
Correlation of breast cancer subtypes, based on estrogen receptor, progesterone receptor, and HER2, with functional imaging parameters from ⁶⁸Ga-RGD PET/CT and ¹⁸F-FDG PET/CT. Eur J Nucl Med Mol Imaging (2014) 1.48
Persistent brain network homology from the perspective of dendrogram. IEEE Trans Med Imaging (2012) 1.41
Ictal SPECT using an attachable automated injector: clinical usefulness in the prediction of ictal onset zone. Acta Radiol (2009) 1.38
Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med (2008) 1.32
Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2008) 1.30
Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med (2009) 1.30
The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma. Cancer Res (2004) 1.30
Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation. J Nucl Med (2008) 1.29
Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol (2006) 1.26
Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small (2011) 1.23
MRP2 haplotypes confer differential susceptibility to toxic liver injury. Pharmacogenet Genomics (2007) 1.23
Tractography-guided statistics (TGIS) in diffusion tensor imaging for the detection of gender difference of fiber integrity in the midsagittal and parasagittal corpora callosa. Neuroimage (2007) 1.22
Pediatric moyamoya disease: An analysis of 410 consecutive cases. Ann Neurol (2010) 1.22
Sparse brain network recovery under compressed sensing. IEEE Trans Med Imaging (2011) 1.19
Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a[15(O)]H2O PET study. Am J Psychiatry (2003) 1.19
Emerging need for vaccination against hepatitis A virus in patients with chronic liver disease in Korea. J Korean Med Sci (2007) 1.18
Bioimaging of the unbalanced expression of microRNA9 and microRNA9* during the neuronal differentiation of P19 cells. FEBS J (2008) 1.17
In vivo imaging of functional targeting of miR-221 in papillary thyroid carcinoma. J Nucl Med (2008) 1.17
Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma. BMC Cancer (2013) 1.16
Usefulness of 11C-methionine PET in the evaluation of brain lesions that are hypo- or isometabolic on 18F-FDG PET. Eur J Nucl Med Mol Imaging (2002) 1.16
Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology (2005) 1.14
Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma. Cytokine (2012) 1.12
Cortical activity at rest predicts cochlear implantation outcome. Cereb Cortex (2006) 1.12
Speech perception after cochlear implantation over a 4-year time period. Acta Otolaryngol (2003) 1.11
Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res (2003) 1.11
Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke (2005) 1.10
HelicoVax: epitope-based therapeutic Helicobacter pylori vaccination in a mouse model. Vaccine (2011) 1.09
Preoperative differences of cerebral metabolism relate to the outcome of cochlear implants in congenitally deaf children. Hear Res (2005) 1.09
Differential features of metabolic abnormalities between medial and lateral temporal lobe epilepsy: quantitative analysis of (18)F-FDG PET using SPM. J Nucl Med (2003) 1.08
Intracranial ganglioglioma: preoperative characteristics and oncologic outcome after surgery. J Neurooncol (2002) 1.07
18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging (2009) 1.06
Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET. Clin Positron Imaging (1999) 1.06
Initial results of simultaneous PET/MRI experiments with an MRI-compatible silicon photomultiplier PET scanner. J Nucl Med (2012) 1.05
FDG uptake, glucose transporter type 1, and Ki-67 expressions in non-small-cell lung cancer: correlations and prognostic values. Eur J Radiol (2007) 1.04
Imaging sensitivity of dedicated positron emission mammography in relation to tumor size. Breast (2011) 1.04
Interferon-gamma promotes abortion due to Brucella infection in pregnant mice. BMC Microbiol (2005) 1.04
(18)F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med (2002) 1.04
Combined encephaloduroarteriosynangiosis and bifrontal encephalogaleo(periosteal)synangiosis in pediatric moyamoya disease. Neurosurgery (2002) 1.03
Spontaneous regression of a large hepatocellular carcinoma with skull metastasis. J Gastroenterol Hepatol (2005) 1.03
Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease. PLoS One (2013) 1.02
11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging (2004) 1.02
Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data. J Nucl Med (2012) 1.02
Prognostic value of volumetric parameters of (18)F-FDG PET in non-small-cell lung cancer: a meta-analysis. Eur J Nucl Med Mol Imaging (2014) 1.01
Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery (2004) 1.01
Kinetic modeling of fenton oxidation of phenol and monochlorophenols. Chemosphere (2002) 1.00
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials (2011) 1.00
Smart magnetic fluorescent nanoparticle imaging probes to monitor microRNAs. Small (2010) 1.00
Noninvasive imaging of microRNA124a-mediated repression of the chromosome 14 ORF 24 gene during neurogenesis. FEBS J (2009) 1.00
Preparation of 18F-human serum albumin: a simple and efficient protein labeling method with 18F using a hydrazone-formation method. Bioconjug Chem (2005) 0.99
A reporter gene imaging system for monitoring microRNA biogenesis. Nat Protoc (2009) 0.99
Metabolic characteristics of Castleman disease on 18F-FDG PET in relation to clinical implication. Clin Nucl Med (2013) 0.99
Discrimination of normal aging, MCI and AD with multimodal imaging measures on the medial temporal lobe. Psychiatry Res (2010) 0.98
Long-term results of lamivudine monotherapy in Korean patients with HBeAg-positive chronic hepatitis B: response and relapse rates, and factors related to durability of HBeAg seroconversion. Intervirology (2005) 0.98
Regional cerebral blood flow in children with attention deficit hyperactivity disorder: comparison before and after methylphenidate treatment. Hum Brain Mapp (2005) 0.98
Decreased renal uptake of (99m)Tc-DMSA in patients with tubular proteinuria. Pediatr Nephrol (2009) 0.98
Development of Korean standard brain templates. J Korean Med Sci (2005) 0.97
Kinetic modeling of 3'-deoxy-3'-18F-fluorothymidine for quantitative cell proliferation imaging in subcutaneous tumor models in mice. J Nucl Med (2008) 0.97
Role of intrahepatic tumor control in the prognosis of patients with hepatocellular carcinoma and extrahepatic metastases. J Gastroenterol Hepatol (2012) 0.97
Combined therapy with 131I and retinoic acid in Korean patients with radioiodine-refractory papillary thyroid cancer. Eur J Nucl Med Mol Imaging (2011) 0.95
In vivo imaging of miR-221 biogenesis in papillary thyroid carcinoma. Mol Imaging Biol (2008) 0.95
Immune response to firefly luciferase as a naked DNA. Cancer Biol Ther (2007) 0.95
Efficacy assessment of cerebral arterial bypass surgery using statistical parametric mapping and probabilistic brain atlas on basal/acetazolamide brain perfusion SPECT. J Nucl Med (2004) 0.95
Development of small-animal PET prototype using silicon photomultiplier (SiPM): initial results of phantom and animal imaging studies. J Nucl Med (2011) 0.94
Rapid synthesis of [18F]FDG without an evaporation step using an ionic liquid. Appl Radiat Isot (2004) 0.94
Evaluation of focal cortical dysplasia and mixed neuronal and glial tumors in pediatric epilepsy patients using 18F-FDG and 11C-methionine pet. J Nucl Med (2010) 0.94
Stable aluminium fluoride chelates with triazacyclononane derivatives proved by X-ray crystallography and 18F-labeling study. Chem Commun (Camb) (2011) 0.93
Decreased cerebral blood flow of the right anterior cingulate cortex in long-term and short-term abstinent methamphetamine users. Drug Alcohol Depend (2005) 0.93
Parietal lobe epilepsy: the semiology, yield of diagnostic workup, and surgical outcome. Epilepsia (2004) 0.93
Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk. Eur J Nucl Med Mol Imaging (2003) 0.92
Bioimaging of nucleolin aptamer-containing 5-(N-benzylcarboxyamide)-2'-deoxyuridine more capable of specific binding to targets in cancer cells. J Biomed Biotechnol (2010) 0.92
[Toxic hepatitis associated with carp juice ingestion]. Korean J Hepatol (2006) 0.91
Voxel-based statistical analysis of cerebral glucose metabolism in the rat cortical deafness model by 3D reconstruction of brain from autoradiographic images. Eur J Nucl Med Mol Imaging (2005) 0.91
[A case of pheochromocytoma with hyperamylasemia]. Korean J Gastroenterol (2003) 0.91
Computing the shape of brain networks using graph filtration and Gromov-Hausdorff metric. Med Image Comput Comput Assist Interv (2011) 0.91
Syntheses of 2-nitroimidazole derivatives conjugated with 1,4,7-triazacyclononane-N,N'-diacetic acid labeled with F-18 using an aluminum complex method for hypoxia imaging. J Med Chem (2012) 0.90
Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds. Eur J Nucl Med Mol Imaging (2008) 0.90
Noninvasive in vivo monitoring of neuronal differentiation using reporter driven by a neuronal promoter. Eur J Nucl Med Mol Imaging (2007) 0.90
Frontal lobe epilepsy: clinical characteristics, surgical outcomes and diagnostic modalities. Seizure (2008) 0.90
Topographic patterns of brain functional impairment progression according to clinical severity staging in 116 Alzheimer disease patients: FDG-PET study. Alzheimer Dis Assoc Disord (2007) 0.90
Age-associated changes of cerebral glucose metabolic activity in both male and female deaf children: parametric analysis using objective volume of interest and voxel-based mapping. Neuroimage (2004) 0.89
Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci (2008) 0.89
Gap compensation during PET image reconstruction by constrained, total variation minimization. Med Phys (2012) 0.89
In vitro derby imaging of cancer biomarkers using quantum dots. Small (2009) 0.89
Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells. J Nucl Med (2007) 0.89
Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT. Lung Cancer (2012) 0.89